NEWAgents can now see video via MCP.Try it now →
    Back to All Lists

    Best AI Medical Imaging Platforms in 2026

    An overview of AI platforms for medical image analysis, including radiology AI, pathology, and clinical image management. Covers FDA clearance status, clinical validation, and integration with healthcare systems.

    Last tested: January 2, 2026
    10 tools evaluated

    How We Evaluated

    Clinical Accuracy

    35%

    Sensitivity, specificity, and validation against clinical outcomes for diagnostic tasks.

    Regulatory Status

    25%

    FDA clearance, CE marking, and compliance with healthcare regulations (HIPAA, GDPR).

    Integration

    20%

    Compatibility with PACS, EHR systems, and standard medical imaging formats (DICOM).

    Deployment Flexibility

    20%

    On-premise, cloud, and hybrid deployment options for different healthcare IT environments.

    Overview

    The AI medical imaging market is split between radiology-focused triage tools like Aidoc and Viz.ai, which have strong FDA clearance track records and proven clinical outcomes, and broader platforms like Tempus and Google Health that combine imaging with genomic or clinical data. Pathology is a distinct sub-market led by PathAI and Paige, where whole-slide image analysis enables drug development and cancer diagnosis. For teams building custom imaging applications — similar case retrieval, training data curation, or research pipelines — general multimodal platforms like Mixpeek offer flexibility that clinical-grade tools cannot, though without FDA clearance they are suited to research and non-diagnostic workflows. The key decision is whether you need a turnkey, FDA-cleared clinical tool or a flexible platform for custom imaging AI applications.
    1

    Aidoc

    FDA-cleared radiology AI platform with 19+ algorithms covering stroke, pulmonary embolism, cervical spine fractures, incidental findings, and aortic emergencies. Deployed in over 1,000 hospitals, Aidoc runs as a background layer on CT scans, triaging critical findings to the top of the radiologist's worklist in real time.

    What Sets It Apart

    Broadest FDA-cleared algorithm portfolio in radiology AI with 19+ cleared use cases across multiple body regions, all running as a single always-on background layer.

    Strengths

    • +19+ FDA-cleared algorithms across body regions
    • +Deployed in 1,000+ hospitals with proven clinical outcomes
    • +Real-time triage that reprioritizes radiologist worklists
    • +Published clinical studies showing reduced time-to-diagnosis

    Limitations

    • -Focused on radiology (CT/X-ray); no pathology or dermatology
    • -Enterprise pricing not publicly available
    • -Requires PACS integration — not plug-and-play
    • -Limited customization; uses Aidoc's pre-built detection models only

    Real-World Use Cases

    • Emergency department CT triage — flagging pulmonary embolism and intracranial hemorrhage within minutes of scan completion
    • Incidental finding detection — catching early-stage aortic aneurysms or lung nodules that might be overlooked during primary reads
    • Radiology workflow optimization — reprioritizing overnight worklists so critical cases are read first by attending radiologists
    • Clinical outcomes tracking — measuring time-to-treatment improvements for stroke and PE cases across hospital systems

    Choose This When

    When your hospital needs a single vendor covering multiple radiology AI use cases with proven FDA clearance and clinical evidence across body regions.

    Skip This If

    When you need pathology, dermatology, or ophthalmology imaging AI, or when you want to build custom detection models on your own data.

    Integration Example

    // Aidoc integrates via PACS/DICOM — no direct API for end users
    // Typical deployment uses HL7/FHIR for worklist integration
    // Example: Consuming Aidoc alerts via FHIR Subscription
    const fhirSubscription = {
      resourceType: "Subscription",
      criteria: "Flag?category=aidoc-alert",
      channel: {
        type: "rest-hook",
        endpoint: "https://your-ehr.example.com/aidoc-alerts",
        payload: "application/fhir+json"
      }
    };
    Enterprise pricing; per-scan or annual subscription models
    Best for: Hospitals and radiology departments needing AI-assisted triage for critical findings
    Visit Website
    2

    Viz.ai

    FDA-cleared AI for stroke detection and care coordination. Analyzes CT angiograms in real time to detect large vessel occlusions (LVO) and automatically alerts stroke teams via mobile app, reducing door-to-treatment times by an average of 26 minutes in published studies. Expanding to pulmonary embolism and aortic disease.

    What Sets It Apart

    Care coordination built into the product — not just detection but automated team notification and workflow orchestration that directly reduces time-to-treatment.

    Strengths

    • +FDA-cleared with published outcomes showing 26-min reduction in treatment time
    • +Automated care team notification via mobile app
    • +Expanding beyond stroke to PE, aortic, and cardiac conditions
    • +Integrates with hospital PACS, EHR, and existing stroke workflows

    Limitations

    • -Narrow focus — primarily neurovascular, expanding slowly
    • -Enterprise healthcare pricing (six-figure annual contracts)
    • -Requires hospital IT integration and clinical champions
    • -Not a general-purpose imaging AI platform

    Real-World Use Cases

    • Large vessel occlusion stroke detection — automated LVO alerts sent directly to neurointerventionalists' phones within minutes of CT angiogram
    • Stroke care coordination — synchronizing ER, neurology, and interventional teams with shared imaging and patient status via mobile app
    • Pulmonary embolism triage — flagging acute PE on CT pulmonary angiograms and routing to the appropriate care team
    • Door-to-groin time reduction — triggering cath lab prep before the patient physically arrives, based on AI-detected LVO

    Choose This When

    When reducing door-to-treatment time for stroke and other time-critical conditions is the primary goal, and you need care coordination alongside detection.

    Skip This If

    When you need general radiology AI covering many body regions, or when you want a platform for non-acute imaging workflows.

    Integration Example

    // Viz.ai uses DICOM routing + mobile app — no public REST API
    // Integration is via PACS router sending studies to Viz.ai node
    // Example: DICOM routing rule (MWL/HL7 config)
    {
      "dicomRouter": {
        "source": "CT_SCANNER_AET",
        "destination": "VIZ_AI_AET",
        "filters": {
          "modality": "CT",
          "bodyPart": ["HEAD", "NECK", "CHEST"]
        },
        "autoRoute": true
      }
    }
    Enterprise pricing; annual subscription per facility
    Best for: Stroke centers and hospitals needing AI-powered neurovascular triage with proven outcomes
    Visit Website
    3

    PathAI

    AI-powered digital pathology platform used by 15 of the top 20 pharmaceutical companies. Analyzes whole-slide images of tissue for oncology diagnosis, biomarker discovery, and drug development. Uses deep learning models trained on millions of pathology images from partnerships with major cancer centers.

    What Sets It Apart

    Deep specialization in oncology pathology with quantitative biomarker scoring validated in clinical trials across 15 of the top 20 pharma companies.

    Strengths

    • +Purpose-built for pathology with deep oncology specialization
    • +Used by 15 of top 20 pharma companies for drug development
    • +Quantitative biomarker scoring for clinical trials
    • +Clinical validation with leading cancer centers (DFCI, Cleveland Clinic)

    Limitations

    • -Pathology-only — no radiology or general imaging support
    • -Enterprise pricing, not accessible for small labs
    • -Requires whole-slide imaging scanner infrastructure
    • -Limited self-service; onboarding is vendor-managed

    Real-World Use Cases

    • Clinical trial biomarker quantification — scoring PD-L1 expression, tumor-infiltrating lymphocytes, and HER2 status on whole-slide images for patient stratification
    • Drug development companion diagnostics — identifying visual biomarkers that predict response to novel therapies across Phase I-III trials
    • Pathologist workflow augmentation — pre-screening slides to highlight regions of interest and suggest differential diagnoses for faster turnaround
    • Cancer research data curation — building structured datasets from millions of annotated pathology images for model training and validation

    Choose This When

    When you are a pharma company running clinical trials that require AI-powered biomarker quantification, or a pathology lab wanting to augment diagnostic workflows with oncology-focused AI.

    Skip This If

    When you need radiology, ophthalmology, or non-pathology imaging AI, or when your lab has not yet invested in whole-slide imaging scanner infrastructure.

    Integration Example

    // PathAI integrates with LIS and digital pathology systems
    // Example: Submitting a case via PathAI's clinical API
    const response = await fetch("https://api.pathai.com/v1/cases", {
      method: "POST",
      headers: {
        "Authorization": "Bearer <PATHAI_API_KEY>",
        "Content-Type": "application/json"
      },
      body: JSON.stringify({
        caseId: "CASE-2026-001",
        slideUrls: ["s3://pathology-slides/case001_HE.svs"],
        stainType: "H&E",
        analysisType: "tumor_detection",
        priority: "routine"
      })
    });
    Enterprise pricing; contact sales for per-slide or subscription models
    Best for: Pathology labs and pharmaceutical companies needing AI-assisted tissue analysis and biomarker research
    Visit Website
    4

    Tempus

    AI-enabled precision medicine platform combining clinical and molecular data with imaging analysis. Uses AI to identify patterns across CT, MRI, and pathology images alongside genomic and clinical data, enabling personalized treatment recommendations.

    What Sets It Apart

    Only platform that fuses imaging AI with genomic sequencing and clinical data at scale, trained on 700K+ real-world patient records for truly multimodal precision medicine.

    Strengths

    • +Combines imaging AI with genomic and clinical data for holistic analysis
    • +Large real-world dataset (700K+ patients) for model training
    • +Multiple FDA-cleared diagnostic products
    • +Supports oncology, cardiology, and neuropsychiatry

    Limitations

    • -Platform-level commitment beyond imaging alone
    • -Enterprise pricing with complex licensing
    • -Data sharing requirements for full platform value
    • -US-focused with limited international availability

    Real-World Use Cases

    • Multimodal cancer treatment planning — correlating tumor imaging features with genomic mutations and clinical history to recommend targeted therapies
    • Clinical trial matching — using imaging phenotypes and molecular profiles to identify patients eligible for precision oncology trials
    • Radiology-genomics research — discovering imaging biomarkers that correlate with specific genetic alterations across large patient cohorts
    • Population health analytics — analyzing imaging and clinical data at scale to identify treatment patterns and outcomes across health systems

    Choose This When

    When your institution wants to combine imaging analysis with genomic and clinical data for comprehensive precision medicine, particularly in oncology.

    Skip This If

    When you only need standalone imaging AI without the broader precision medicine platform, or when data sharing agreements are a blocker for your organization.

    Integration Example

    // Tempus provides platform APIs for clinical data integration
    // Example: Querying patient imaging + genomic data
    const tempusClient = new TempusAPI({ apiKey: TEMPUS_KEY });
    
    const patientProfile = await tempusClient.patients.get({
      patientId: "PT-12345",
      include: ["imaging", "genomics", "clinical"]
    });
    
    // Correlate imaging features with genomic data
    const insights = await tempusClient.analytics.correlate({
      imagingFeatures: patientProfile.imaging.tumorFeatures,
      genomicProfile: patientProfile.genomics.mutations,
      analysisType: "treatment_recommendation"
    });
    Enterprise pricing; varies by product module and institution size
    Best for: Health systems wanting AI that combines imaging with genomic and clinical data for precision medicine
    Visit Website
    5

    Google Health AI (MedLM)

    Google's healthcare AI models including Med-PaLM 2 (which scored 85.4% on USMLE-style questions) and AMIE for diagnostic dialogue. Offers dermatology AI that achieved dermatologist-level accuracy in studies, and medical imaging research across retinal, mammography, and chest X-ray domains.

    What Sets It Apart

    Combines frontier foundation model capabilities (Med-PaLM 2, AMIE) with Google-scale infrastructure and active research across multiple imaging modalities.

    Strengths

    • +Med-PaLM 2 scored 85.4% on medical exam questions — expert level
    • +Dermatology AI matching specialist accuracy in clinical studies
    • +Active research across retinal disease, cancer screening, and radiology
    • +Google Cloud infrastructure with HIPAA BAA available

    Limitations

    • -Most capabilities still in research/preview — limited production products
    • -GCP dependency for deployment
    • -Not a turnkey clinical solution; requires significant integration work
    • -Regulatory clearance pathway unclear for many products

    Real-World Use Cases

    • Diabetic retinopathy screening — deploying Google's retinal imaging AI in community clinics for early detection without an ophthalmologist on-site
    • Dermatology triage — using AI to assess skin condition photos from patients and route urgent cases to dermatologists faster
    • Chest X-ray pre-screening — flagging abnormal findings in high-volume screening programs to prioritize radiologist review
    • Clinical decision support — using MedLM to synthesize imaging findings with patient history for differential diagnosis suggestions

    Choose This When

    When you are a research institution or health system already on GCP that wants to explore cutting-edge medical AI capabilities and can handle integration complexity.

    Skip This If

    When you need FDA-cleared, production-ready clinical tools today, or when GCP lock-in is unacceptable for your organization.

    Integration Example

    // Google Health AI via Vertex AI / MedLM endpoint
    import { VertexAI } from "@google-cloud/vertexai";
    
    const vertex = new VertexAI({
      project: "your-healthcare-project",
      location: "us-central1"
    });
    
    const model = vertex.getGenerativeModel({
      model: "medlm-large",
    });
    
    const result = await model.generateContent({
      contents: [{
        role: "user",
        parts: [
          { text: "Analyze this chest X-ray for abnormalities:" },
          { inlineData: { mimeType: "image/png", data: xrayBase64 } }
        ]
      }]
    });
    Google Cloud pricing; healthcare-specific pricing via sales
    Best for: Research institutions and health systems exploring next-generation clinical AI with Google Cloud
    Visit Website
    6

    Paige

    AI-powered digital pathology platform with the first FDA-approved AI product for cancer detection in pathology (Paige Prostate). Uses deep learning trained on over 2 million pathology slides from Memorial Sloan Kettering to detect cancer in prostate biopsies and other tissue types with clinical-grade accuracy.

    What Sets It Apart

    First and only FDA-approved AI for cancer detection in pathology, built on the world's largest clinically annotated pathology dataset from Memorial Sloan Kettering.

    Strengths

    • +First FDA-approved AI for cancer detection in pathology slides
    • +Trained on 2M+ slides from Memorial Sloan Kettering partnership
    • +Clinical-grade accuracy for prostate cancer detection (97.7% sensitivity)
    • +Expanding to breast, colorectal, and other cancer types

    Limitations

    • -Currently limited to specific cancer types (prostate most mature)
    • -Requires whole-slide imaging infrastructure and digital pathology workflow
    • -Enterprise pricing not accessible for small community labs
    • -Fewer pharma partnerships than PathAI for drug development use cases

    Real-World Use Cases

    • Prostate biopsy screening — AI-assisted detection of cancer on H&E slides with 97.7% sensitivity to catch missed diagnoses
    • Second-read quality assurance — running AI as a parallel reader to flag cases where pathologist and AI disagree for additional review
    • High-volume lab throughput — prioritizing positive cases in labs processing hundreds of prostate biopsies daily
    • Pathologist training — using AI-annotated slides as educational tools for residents learning cancer morphology

    Choose This When

    When you need FDA-approved AI for prostate cancer detection in clinical pathology workflows, or when regulatory status is a hard requirement.

    Skip This If

    When you need AI for drug development and clinical trial biomarker quantification (PathAI is stronger), or when your lab has not adopted digital pathology workflows.

    Integration Example

    // Paige integrates with digital pathology systems via HL7/DICOM
    // Example: Submitting a slide for Paige Prostate analysis
    const response = await fetch("https://api.paige.ai/v1/analyze", {
      method: "POST",
      headers: {
        "Authorization": "Bearer <PAIGE_API_KEY>",
        "Content-Type": "application/json"
      },
      body: JSON.stringify({
        slideId: "SLIDE-2026-0042",
        slideUrl: "s3://pathology/slides/case42_HE.svs",
        analysisType: "prostate_cancer_detection",
        returnHeatmap: true
      })
    });
    Enterprise pricing; per-slide or annual subscription for clinical deployments
    Best for: Clinical pathology labs needing FDA-approved AI-assisted cancer detection, particularly for prostate biopsies
    Visit Website
    7

    Arterys (Tempus Radiology)

    Cloud-native AI radiology platform, now part of Tempus, offering FDA-cleared cardiac MRI analysis and a marketplace of third-party radiology AI applications. Pioneered cloud-based medical image viewing with real-time 4D flow analysis for cardiac imaging.

    What Sets It Apart

    Pioneered cloud-native medical image analysis with zero on-premise infrastructure, featuring a marketplace model for curated third-party AI algorithms.

    Strengths

    • +FDA-cleared cardiac MRI analysis with 4D flow visualization
    • +Cloud-native architecture — no on-premise hardware required
    • +AI marketplace model with curated third-party algorithms
    • +Fast deployment via web-based viewer integrated with PACS

    Limitations

    • -Now absorbed into Tempus — standalone roadmap uncertain
    • -Cloud-only deployment may not meet all data residency requirements
    • -Smaller algorithm library compared to Aidoc's breadth
    • -Cardiac MRI is a niche use case for most hospitals

    Real-World Use Cases

    • Cardiac MRI quantification — automated ventricular volume, ejection fraction, and strain analysis from 4D flow MRI sequences
    • Multi-vendor AI aggregation — deploying algorithms from multiple vendors through a single marketplace interface connected to PACS
    • Remote cardiac imaging reads — enabling cardiologists to access AI-enhanced MRI analysis from any location via cloud viewer
    • Longitudinal cardiac monitoring — tracking changes in cardiac function across serial MRI exams with automated measurements

    Choose This When

    When you want cloud-based cardiac MRI AI without on-premise hardware, or when you want a marketplace approach to evaluating multiple radiology AI algorithms.

    Skip This If

    When you need on-premise deployment for data sovereignty, or when cardiac MRI is not a priority and you need broader radiology coverage.

    Integration Example

    // Arterys cloud-native viewer — DICOM push to cloud
    // Studies are routed to Arterys via DICOM gateway
    {
      "dicomGateway": {
        "localAET": "PACS_MAIN",
        "remoteAET": "ARTERYS_CLOUD",
        "remoteHost": "dicom.arterys.com",
        "remotePort": 4242,
        "modalities": ["MR"],
        "bodyParts": ["HEART"],
        "autoForward": true
      }
    }
    Part of Tempus platform; previously $50K-150K annually per site
    Best for: Cardiac imaging centers needing cloud-based AI for MRI analysis and multi-vendor algorithm access
    Visit Website
    8

    Lunit

    South Korean AI medical imaging company with FDA-cleared and CE-marked products for chest X-ray analysis (Lunit INSIGHT CXR) and mammography (Lunit INSIGHT MMG). Deployed in 5,000+ institutions across 50+ countries with published validation showing radiologist-level performance on tuberculosis, lung nodules, and breast cancer detection.

    What Sets It Apart

    Strongest global deployment footprint with 5,000+ institutions and 100+ peer-reviewed publications validating stand-alone reader performance across chest X-ray and mammography.

    Strengths

    • +FDA-cleared and CE-marked for both chest X-ray and mammography
    • +Deployed in 5,000+ institutions across 50+ countries
    • +Strong clinical evidence with 100+ peer-reviewed publications
    • +Stand-alone reader performance validated in prospective studies

    Limitations

    • -Focused on two modalities (chest X-ray, mammography) only
    • -Strongest market presence in Asia — less well-known in US/EU
    • -Requires PACS integration similar to other clinical AI tools
    • -Enterprise pricing; not available for individual clinicians

    Real-World Use Cases

    • Tuberculosis screening programs — deploying chest X-ray AI in high-burden regions to screen populations without radiologist access
    • Breast cancer screening augmentation — using AI as a second reader on screening mammograms to reduce false negatives
    • Lung nodule follow-up tracking — automatically measuring and tracking lung nodules across sequential chest X-rays
    • Emergency department chest X-ray triage — prioritizing abnormal chest films for faster radiologist interpretation

    Choose This When

    When you need clinically validated, globally deployed AI for chest X-ray screening (especially TB) or mammography with strong evidence from prospective studies.

    Skip This If

    When you need AI for modalities beyond chest X-ray and mammography, or when you are looking for a US-based vendor with domestic support infrastructure.

    Integration Example

    // Lunit INSIGHT integrates via DICOM and provides REST API
    const response = await fetch("https://api.lunit.io/v1/inference", {
      method: "POST",
      headers: {
        "Authorization": "Bearer <LUNIT_API_KEY>",
        "Content-Type": "application/json"
      },
      body: JSON.stringify({
        studyId: "STUDY-2026-789",
        modality: "CR",  // chest radiograph
        dicomUrl: "dicom://pacs.hospital.org/study/789",
        product: "INSIGHT_CXR",
        returnHeatmap: true
      })
    });
    Enterprise pricing; annual subscription per modality per facility
    Best for: Hospitals and screening programs needing FDA-cleared AI for chest X-ray and mammography with strong global validation data
    Visit Website
    9

    Mixpeek

    Our Pick

    Multimodal AI platform for building custom medical imaging applications. While not FDA-cleared for clinical diagnosis, Mixpeek's pipeline processes DICOM and standard image formats with configurable feature extractors for similarity search, classification, and retrieval across imaging datasets. Suited for research, training data management, and building applications reviewed by clinical professionals.

    What Sets It Apart

    Only platform on this list offering a general-purpose multimodal pipeline that researchers and health-tech builders can customize for any imaging use case without being locked into pre-built clinical models.

    Strengths

    • +Flexible multimodal pipeline handles DICOM, PNG, JPEG, and video
    • +Build custom similarity search across imaging datasets in hours
    • +Configurable feature extractors — swap models without re-architecting
    • +Self-hosted deployment option for HIPAA-compliant environments

    Limitations

    • -Not FDA-cleared — cannot be used as standalone clinical decision support
    • -No pre-built clinical detection models (stroke, cancer, etc.)
    • -Requires ML expertise to configure for medical imaging workflows
    • -No PACS integration out of the box

    Real-World Use Cases

    • Similar case retrieval — building a search engine across historical radiology studies to find visually similar cases for differential diagnosis support
    • Training data curation — organizing and deduplicating millions of medical images for ML model training with embedding-based clustering
    • Medical education platforms — enabling students to search imaging databases by visual similarity and anatomical features
    • Clinical trial image management — indexing and retrieving imaging data across multi-site trials with custom metadata extraction

    Choose This When

    When you are building a custom medical imaging application — similar case retrieval, dataset curation, or research tools — and need a flexible multimodal platform rather than a turnkey clinical product.

    Skip This If

    When you need FDA-cleared clinical decision support for direct patient care, or when you want pre-built detection models for specific conditions without custom development.

    Integration Example

    import Mixpeek from "mixpeek";
    
    const client = new Mixpeek({ apiKey: "MIXPEEK_API_KEY" });
    
    // Upload a medical image for processing
    const asset = await client.assets.upload({
      file: dicomImageBuffer,
      collection: "radiology-cases",
      metadata: { modality: "CT", bodyPart: "chest", patientAge: 65 }
    });
    
    // Find visually similar cases
    const similar = await client.search.query({
      queries: [{ type: "file", value: queryImageUrl }],
      collections: ["radiology-cases"],
      top_k: 10
    });
    Usage-based pricing from $0 (free tier); self-hosted enterprise options available
    Best for: Research teams and health-tech companies building custom medical imaging applications, similar-case retrieval, and training data management systems
    Visit Website
    10

    Qure.ai

    AI-powered radiology platform focused on making imaging AI accessible in resource-limited settings. FDA-cleared and CE-marked products cover chest X-ray, head CT, and spine analysis. Deployed in 90+ countries with strong traction in public health tuberculosis screening programs and emergency triage in low-resource hospitals.

    What Sets It Apart

    Purpose-built for accessibility in resource-limited settings with edge deployment, affordable pricing, and validation in 90+ countries including public health TB screening programs.

    Strengths

    • +FDA-cleared and CE-marked for chest X-ray, head CT, and spine
    • +Deployed in 90+ countries including underserved healthcare markets
    • +Strong public health focus — TB screening at population scale
    • +Works on standard hardware without GPU requirements at point of care

    Limitations

    • -Less known in US/EU enterprise hospital markets
    • -Fewer algorithms than Aidoc for comprehensive radiology AI
    • -Limited pathology and non-radiology imaging coverage
    • -Smaller clinical evidence base compared to Lunit for mammography

    Real-World Use Cases

    • National TB screening programs — deploying chest X-ray AI across community health centers to screen populations without radiologists
    • Emergency head CT triage — detecting intracranial hemorrhage, midline shift, and fractures in emergency departments with limited specialist coverage
    • Spine fracture detection — automated identification of vertebral compression fractures on CT and X-ray for osteoporosis screening
    • Mobile screening vans — running AI analysis on portable X-ray equipment in remote and rural healthcare settings

    Choose This When

    When you need radiology AI that works in low-resource environments, supports public health screening programs, or need affordable deployment in developing healthcare markets.

    Skip This If

    When you need comprehensive enterprise radiology AI for a well-resourced hospital system, or when mammography and advanced cardiac imaging are priorities.

    Integration Example

    // Qure.ai provides cloud API and edge deployment options
    const response = await fetch("https://api.qure.ai/v2/analyze", {
      method: "POST",
      headers: {
        "Authorization": "Bearer <QURE_API_KEY>",
        "Content-Type": "application/json"
      },
      body: JSON.stringify({
        studyUid: "1.2.840.113619.2.55.12345",
        modality: "CR",
        product: "qXR",  // chest X-ray AI
        returnFindings: true,
        returnHeatmap: true,
        callbackUrl: "https://your-system.example.com/results"
      })
    });
    Tiered pricing; affordable options designed for public health programs and developing markets
    Best for: Public health organizations and hospitals in resource-limited settings needing accessible, validated radiology AI for screening programs
    Visit Website

    Frequently Asked Questions

    Is AI for medical imaging FDA approved?

    Many AI medical imaging products have received FDA clearance (510(k) pathway) or De Novo classification. As of 2026, over 500 AI/ML medical devices have been authorized by the FDA. However, 'clearance' differs from 'approval' -- most devices are cleared through the 510(k) pathway, which demonstrates substantial equivalence to existing devices rather than independent clinical validation. Always verify current clearance status.

    Can general AI platforms be used for medical imaging?

    General platforms like Mixpeek can power custom medical imaging applications (search, classification, retrieval) but should not be used as standalone clinical decision support without proper validation and regulatory approval. They are well-suited for research, training data management, similar case retrieval, and building applications that are reviewed by clinical professionals.

    What compliance requirements apply to medical imaging AI?

    Key requirements include HIPAA compliance (US), GDPR (EU), FDA clearance for clinical use (US), CE marking (EU), and healthcare-specific data handling standards. Self-hosted deployment options are critical for meeting data residency requirements. All medical AI should be validated on representative patient populations before clinical deployment.

    How accurate is AI at detecting diseases in medical images?

    Leading AI systems achieve radiologist-level accuracy for specific tasks. For example, FDA-cleared stroke detection achieves sensitivity above 95% for large vessel occlusions. However, accuracy varies significantly by condition, imaging modality, and patient population. AI performs best as a tool that augments radiologist decision-making rather than replacing it entirely.

    Ready to Get Started with Mixpeek?

    See why teams choose Mixpeek for multimodal AI. Book a demo to explore how our platform can transform your data workflows.

    Explore Other Curated Lists

    multimodal ai

    Best Multimodal AI APIs

    A hands-on comparison of the top multimodal AI APIs for processing text, images, video, and audio through a single integration. We evaluated latency, modality coverage, retrieval quality, and developer experience.

    11 tools rankedView List
    search retrieval

    Best Video Search Tools

    We tested the leading video search and understanding platforms on real-world content libraries. This guide covers visual search, scene detection, transcript-based retrieval, and action recognition.

    9 tools rankedView List
    content processing

    Best AI Content Moderation Tools

    We evaluated content moderation platforms across image, video, text, and audio moderation. This guide covers accuracy, latency, customization, and compliance features for trust and safety teams.

    9 tools rankedView List